HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2.

Abstract
The oxidation of plasma LDLs (low-density lipoproteins) is a key event in the pathogenesis of atherosclerosis. LPC (lysophosphatidylcholine) and oxysterols are major lipid constitutents of oxidized LDLs. In particular, 7-oxocholesterol has been found in plasma from cardiac patients and atherosclerotic plaque. In the present study, we investigated the ability of 7-oxocholesterol and LPC to regulate the activation of eNOS (endothelial nitric oxide synthase) and cPLA2 (cytosolic phospholipase A2) that synthesize two essential factors for vascular wall integrity, NO (nitric oxide) and arachidonic acid. In endothelial cells from human umbilical vein cords, both 7-oxocholesterol (150 microM) and LPC (20 microM) decreased histamine-induced NO release, but not the release activated by thapsigargin. The two lipids decreased NO release through a PI3K (phosphoinositide 3-kinase)-dependent pathway, and decreased eNOS phosphorylation. Their mechanisms of action were, however, different. The NO release reduction was dependent on superoxide anions in LPC-treated cells and not in 7-oxocholesterol-treated ones. The Ca2+ signals induced by histamine were abolished by LPC, but not by 7-oxocholesterol. The oxysterol also inhibited (i) the histamine- and thapsigargin-induced arachidonic acid release, and (ii) the phosphorylation of both cPLA2 and ERK1/2 (extracellular-signal-regulated kinases 1/2). The results show that 7-oxocholesterol inhibits eNOS and cPLA2 activation by altering a Ca2+-independent upstream step of PI3K and ERK1/2 cascades, whereas LPC desensitizes eNOS by interfering with receptor-activated signalling pathways. This suggests that 7-oxocholesterol and LPC generate signals which cross-talk with heterologous receptors, effects which could appear at early stage of atherosclerosis.
AuthorsElisabeth Millanvoye-Van Brussel, Gökce Topal, Annie Brunet, Thuc Do Pham, Valérie Deckert, Francine Rendu, Monique David-Dufilho
JournalThe Biochemical journal (Biochem J) Vol. 380 Issue Pt 2 Pg. 533-9 (Jun 01 2004) ISSN: 1470-8728 [Electronic] England
PMID14992685 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ketocholesterols
  • Lipoproteins, LDL
  • Lysophosphatidylcholines
  • Arachidonic Acid
  • Nitric Oxide
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • Phospholipases A
  • Phospholipases A2
  • 7-ketocholesterol
Topics
  • Arachidonic Acid (metabolism)
  • Calcium Signaling (physiology)
  • Cytosol (enzymology)
  • Endothelium, Vascular (cytology, enzymology, metabolism)
  • Enzyme Activation (physiology)
  • Humans
  • Ketocholesterols (physiology)
  • Lipid Metabolism
  • Lipoproteins, LDL (chemistry, metabolism)
  • Lysophosphatidylcholines (metabolism)
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases (metabolism)
  • Nitric Oxide (metabolism, physiology)
  • Nitric Oxide Synthase (metabolism)
  • Nitric Oxide Synthase Type III
  • Phospholipases A (metabolism)
  • Phospholipases A2
  • Phosphorylation
  • Umbilical Veins (cytology, enzymology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: